Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference66 articles.
1. Zbinden, G. Biotechnology products intended for human use, toxicological targets and research strategies. Prog. Clin. Biol. Res. 235, 143–159 (1987).
2. Claude, J. R. Difficulties in conceiving and applying guidelines for the safety evaluation of biotechnologically produced drugs: some examples. Toxicol. Lett. 64–65, 349–355 (1992).
3. Cavagnaro, J. A. Science-based approach to preclinical safety evaluation of biotechnology products. Pharm. Eng. 12, 32–33 (1992).
4. Dayan, A. D. Safety evaluation of biological and biotechnology-derived medicines. Toxicology 105, 59–68 (1995).
5. Maki, E. Safety assessment of biotechnology-derived pharmaceutical products. General principles and the relevant cases. J. Toxicol. Sci. 21, 531–534 (1996).
Cited by
95 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献